3 replies to this topic

[akela]

January 14, 2010: WPI Announces Availability of Updated XMRV Testing

Whittemore Peterson Institute Announces Availability of Updated XMRV Testing
-UK Study Publication Does Not Impact XMRV Research

In October 2009, together with the Cleveland Clinic and National Cancer Institute, the Whittemore Peterson Institute published findings in Science regarding the discovery of XMRV in the blood of Chronic Fatigue Syndrome (CFS) patients. The testing method, validated in multiple other labs using positive control samples, uses a unique process that was extensively peer reviewed before publication and provides the most accurate results available.
This virus culture test is the same method used in the Science publication, and the only scientifically validated methodology to find XMRV. Some labs, including the recent study published in the U.K., have used non-validated PCR and whole blood PCR assays. At this time no single PCR or whole blood assay alone has been validated as accurately detecting XMRV, and is therefore not an appropriate way to study or diagnose the presence of the virus.
WPI has licensed the latest version of the test to Viral Immune Pathways Diagnostic Laboratories (VIP Dx) in Reno, Nev. The non-exclusive license allows patients and their doctors access to a reliable diagnostic tool. The newly refined test uses a virus culture methodology that yields more reliable results in one test at a lower cost to patients.
“Our mission at WPI is to discover bio markers of disease and translate those discoveries into accurate diagnostics and effective treatments for patients,” said WPI Founder and President Annette Whittemore. “We continue to talk to other clinical laboratory companies, both nationally and internationally, in order to make the test available to a wider audience.”
WPI Research Scientist and co-author of the Science paper, Dr. Vincent Lombardi (*), is providing technical assistance and oversight of the VIP Dx testing. In exchange for the non-exclusive license, VIP Dx will pay a royalty to WPI for each test it conducts.

(*)
Dovrebbe essere questo

http://www.dbag.unif...o/vincenzo.html

http://www.dbag.unif...Lombardi_V.html

[akela]

January 14, 2010: WPI Announces Availability of Updated XMRV Testing

Whittemore Peterson Institute Announces Availability of Updated XMRV Testing
-UK Study Publication Does Not Impact XMRV Research

In October 2009, together with the Cleveland Clinic and National Cancer Institute, the Whittemore Peterson Institute published findings in Science regarding the discovery of XMRV in the blood of Chronic Fatigue Syndrome (CFS) patients. The testing method, validated in multiple other labs using positive control samples, uses a unique process that was extensively peer reviewed before publication and provides the most accurate results available.
This virus culture test is the same method used in the Science publication, and the only scientifically validated methodology to find XMRV. Some labs, including the recent study published in the U.K., have used non-validated PCR and whole blood PCR assays. At this time no single PCR or whole blood assay alone has been validated as accurately detecting XMRV, and is therefore not an appropriate way to study or diagnose the presence of the virus.
WPI has licensed the latest version of the test to Viral Immune Pathways Diagnostic Laboratories (VIP Dx) in Reno, Nev. The non-exclusive license allows patients and their doctors access to a reliable diagnostic tool. The newly refined test uses a virus culture methodology that yields more reliable results in one test at a lower cost to patients.
“Our mission at WPI is to discover bio markers of disease and translate those discoveries into accurate diagnostics and effective treatments for patients,” said WPI Founder and President Annette Whittemore. “We continue to talk to other clinical laboratory companies, both nationally and internationally, in order to make the test available to a wider audience.”
WPI Research Scientist and co-author of the Science paper, Dr. Vincent Lombardi (*), is providing technical assistance and oversight of the VIP Dx testing. In exchange for the non-exclusive license, VIP Dx will pay a royalty to WPI for each test it conducts.

(*)
Dovrebbe essere questo

http://www.dbag.unif...o/vincenzo.html

http://www.dbag.unif...Lombardi_V.html

Mi è venuto il dubbio che non sia quello, ma uno che sta in America.
Comunque Tirelli o la Carlo-Stella si dovrebbero mettere in contatto con il WPI.

[Zac]

So del dr Lorusso, dell'Associazione di Pavia, che è in contatto (amico ?) di Kerr, che a sua volta collabora con il WPI sulla ricerca der retrovirus.

[akela]

So del dr Lorusso, dell'Associazione di Pavia, che è in contatto (amico ?) di Kerr, che a sua volta collabora con il WPI sulla ricerca der retrovirus.

Ah, bene.